JOSE ANTONY PAUL: Open Payments
NPI 1629219936 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 31 payments from 13 companies in 2025. Trend: 2023 $2,210 · 2024 $825 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $197 |
| AstraZeneca Pharmaceuticals LP | 8 | $184 |
| Olympus America Inc. | 1 | $147 |
| Grifols USA, LLC | 3 | $70 |
| GENZYME CORPORATION | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| PFIZER INC. | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Baxter Healthcare | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: Spiration Valve System, TRELEGY ELLIPTA, DUPIXENT, TEZSPIRE, Prolastin-C Liquid, NUCALA, FASENRA, BREZTRI.
Industry payments across GA — which companies pay providers there.
